Endovascular Procedures
Conditions
Brief summary
With new developments that have taken place in the optimization of C-arm computed tomography (CACT) image acquisition and reconstruction, CACT image quality will be better than current standard-of-care CACT scan techniques used for neurovascular patients referred to endovascular treatment or diagnosis. As such, novel acquisition, filtration, artifact reduction and reconstruction techniques will be evaluated against the standard-of-care CACT approach.
Detailed description
This prospective observational study aims to enroll 50 patients diagnosed with various neurovascular conditions with the goal to compare the image quality of new types of head C-arm computed tomography (CACT) image scans with standard CACT scans, and also to compare these novel scans with standard CT scan image quality. These new scans use novel acquisition, filtration and reconstruction techniques compared to the standard-of-care CACT scans being used in the neuroangiography suite at the present time. Patient selection will be based on a suitability of patients for neuro-endovascular interventions in the neuroangiography suite. All research related activities will be done by study team members. The study patients are expected to follow their routine treatment schedule with the exception of 1 extra CACT scan while patient is receiving their standard treatment.
Interventions
PROCEDURENeurovascular percutaneous intervention
Patient will receive one extra CACT scan while they are receiving percutaneous neurovascular intervention.
Sponsors
Philips Healthcare
University Health Network, Toronto
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Subject is suitable for an endovascular treatment in the neuro-angiography suite. 2. Subject or subject's legally authorized representative has signed an institutionally approved research informed consent form. 3. Subject ≥ 18 years old.
Exclusion criteria
1. Subject or subject's legally authorized representative is unable or unwilling to consent to the study. 2. Subject had prior significant or severe allergy to intra-arterial contrast medium uncontrolled by pre-procedure medications. 3. Subject with documented contrast injection contraindication due to severe kidney disease or allergy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with improved new CACT image quality compared to standard CACT based on a 5-point Likert scale | 1 year | To achieve a brain parenchyma image quality with CACT using novel acquisition, filtration, artifact reduction and reconstruction techniques that is better than current standard-of-care CACT approaches, based on a 5-point Likert scoring scale questionnaire for each patient. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with a CACT image quality at the same level or better as standard CT based on a 5-point Likert scale | 1 year | Achieve CACT image quality equivalent to or better than standard CT scans (if available) in patients with neurovascular diseases or conditions. This comparison will be done based on a 5-point Likert scoring scale questionnaire for each patient. |
| Number of participants with improved or equivalent contrast-to-noise ratio using new CACT vs. standard CT scans | 1 year | Contrast-to-noise ratio (unitless quantity) equivalent or higher in new CACT images compared to standard CT images, measured using regions of interest in image processing software. |
| Number of participants with improved contrast-to-noise ratio using new CACT vs. standard CACT | 1 year | Contrast-to-noise ratio (unitless quantity) higher in new CACT images compared to standard CACT images, measured using regions of interest in image processing software. |
Countries
Canada
Contacts
Primary ContactVitor Pereira, MD
Backup ContactAlex Kostynskyy, MBBS
Outcome results
None listed